Teraplast Group reported a challenging Q1 2026, with revenue declining 6% year-over-year to RON 236 million, down from RON 249 million in Q1 2025.
The company posted a net loss of RON 10.6 million, compared to a profit of RON 1.2 million in the same quarter last year. The stock remained unchanged at 0.422 RON, near its 52-week low.
Executives cited severe winter weather, geopolitical tensions, and delayed public investments as key factors. They remain optimistic about recovery in later quarters, supported by EU fund inflows and operational improvements.
